The 68th annual scientific meeting of the British Society for Research on Aging will take place on September 6-8th at Oriel College, Oxford, UK. This year's theme is "Ageing here and now: current research and transformative therapies".

Professor Vera Gorbunova discussed how comparative biology revealed a possible role in age-related disease for retrotransposons (self-copying sequences of "junk" DNA that make up much of our genome), and shared some initial progress in countering their effects.

Dr. Aubrey de Grey discussed the feasibility and moral urgency of developing rejuvenation biotechnologies in an interview with ada, a new digital magazine from the publishers of German business weekly Wirtschaftswoche. (Article in German.)

Want to work for SRF? We are now hiring for a full time Administrative Assistant position to perform administrative and some accounting tasks at our Research Center in Mountain View, CA.

Check out all the latest news from SENS Research Foundation in our August newsletter. You might also like to check out the archive of past messages, or subscribe to our mailing list to make sure you don't miss out on future updates!

Nuchido CEO Dr. Nichola Conlon presented an overview of aging and potential treatments from a network science perspective, before sharing some promising initial results in reversing the decline of NAD⁺ levels - thought to be a key factor in age-related degeneration.

Youthereum Genetics CEO Yuri Deigin recently interviewed Dr. Aubrey de Grey for Lifespan.io, leading to a very broad-ranging discussion that covers the history of SENS as well as recent progress and plans for the future. (Also available in Russian.)

Doug Ethell, Founder and CEO of Leucadia Therapeutics, introduced their novel therapeutic approach to Alzheimer's disease: repairing age-related damage to the brain's "drainage system", and thus restoring the body's natural ability to clear pathological proteins such as amyloids.

Humble Bundle, the gaming and ebook store famous for its innovative "pay what you want" pricing scheme, has raised more than $100 million for charity since its founding in 2010 - and its customers can now select SENS Research Foundation as their nominated beneficiary!

SRF was a founding investor in Oisín Biotechnologies, whose programmable gene therapy is a promising alternative to small-molecule senolytic drugs - and who have now released preliminary mouse lifespan data demonstrating a major reduction in age-related mortality.

"The year is 2218. Ageing has been cured. Society is not what it used to be..." The first podcast in a new future-facing series sponsored by South African financial services giant Sanlam has just been released, featuring quotes from SRF CSO Dr. Aubrey de Grey.

Following the incredible success of the 2018 event, SRF and Forever Healthy Foundation are delighted to confirm that Undoing Aging 2019 will take place at the Umspannwerk Alexanderplatz in Berlin from March 28-30 (Facebook event). Early bird tickets are now available!

We're seeking a full-time researcher for a Scientist I position at our Research Center in California, to lead a new intramural research project performing translational research studying aging as it relates to the immune system.